Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000971
Filing Date
2025-08-27
Accepted
2025-08-27 10:42:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2900
  Complete submission text file 0002007317-25-000971.txt   4309
Mailing Address 89 MELROSE DRIVE MISSION VIEJO CA 92692
Business Address
Pham Quang X (Reporting) CIK: 0001405290 (see all company filings)

 

Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Subject) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41596 | Film No.: 251261148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)